Cord Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationTransplantation, AutologousBone Marrow TransplantationGraft vs Host DiseaseTransplantation ConditioningFetal BloodTissue DonorsGraft SurvivalHematologic NeoplasmsGraft vs Tumor EffectKidney TransplantationHistocompatibility TestingLeukemiaTreatment OutcomeGraft RejectionWhole-Body IrradiationSpinal CordRecurrenceBusulfanTransplantsImmunosuppressive AgentsTime FactorsRetrospective StudiesRemission InductionLeukemia, Myeloid, AcuteBlood Transfusion, AutologousSurvival AnalysisCombined Modality TherapyHeart TransplantationSpinal Cord InjuriesT-LymphocytesStem Cell TransplantationGranulocyte Colony-Stimulating FactorTransplantation ChimeraLymphocyte Culture Test, MixedSurvival RateTransplantationIsoantigensImmunosuppressionHistocompatibilityTransplantation ImmunologyDisease-Free SurvivalTransplantation, IsogeneicLung TransplantationCyclosporineAntigens, CD34Cytomegalovirus InfectionsBlood BanksHematopoietic Stem CellsUmbilical CordLymphocyte ActivationHLA AntigensSkin TransplantationTacrolimusGraft vs Leukemia EffectPeripheral Blood Stem Cell TransplantationCytotoxicity, ImmunologicInfant, NewbornCells, CulturedLiving DonorsTissue and Organ ProcurementPostoperative ComplicationsMyeloablative AgonistsFollow-Up StudiesAcute DiseaseMice, Inbred C57BLFlow CytometryDendritic CellsFetal Tissue TransplantationGraft vs Host ReactionTransplantation ToleranceLymphocyte DepletionLymphocytesMice, Inbred BALB CAnemia, AplasticImmunophenotypingAntigens, CDAntilymphocyte SerumPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunocompromised HostCell SeparationBone Marrow CellsT-Lymphocytes, CytotoxicImmune ToleranceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCyclophosphamideCytomegalovirusWaiting ListsSpleen